Home  >  Health Check  >  FDA approves new Alzheimer’s drug
Health Check
FDA approves new Alzheimer’s drug
Health Check
Jun 9, 2021

Aducanumab the controversial new drug for Alzheimer’s disease, just approved by the FDA in the US is the first approved breakthrough in nearly 20 years. But, as Sarah Boseley explains, scientists dispute the drug’s effectiveness.

Good news from a study published in Lancet Healthy Longevity looking at protection levels from getting Covid. It studied the risk of COVID reinfection in care home staff and occupants up to 10 months after first being unwell and showed substantial levels of protection is retained.

And a new paper on Vitamin D deficiency in Africa – the first large prevalence study in children on the continent.

Plus bestselling author and gynaecologist Dr Jen Gunter on her Menopause Manifesto, part two in our mini-series on Health Check. Dr Gunter unpicks the facts and feminism of how society’s focus on what happens to women’s bodies has shaped and hindered treatment for the menopause.

Presenter: Claudia Hammond Producer: Erika Wright

Image: Abstract medical icon of head showing Alzheimer's memory loss due to dementia and brain disease Credit: wildpixel/Getty Images

More Episodes
May 20, 2026
Ebola outbreak in the Democratic Republic of Congo

An Ebola outbreak that started in the north-east of the Democratic Republic of Congo (DRC) is spreading in the region and has been declared a health emergency. Health Check’s Claudia Hammond has the latest with BBC reporter Emery Makumeno in Kinshasa, Heather Kerr, Country Director for the International Rescue Committee (IRC) in the DRC, and Professor Trudie Lang, head of the Global Health Network at Oxford University.

Claudia is joined in the studio by BBC health reporter Laura Foster. They discuss the call for more testing of drugs with under-represented groups, after a study of Black African Americans, smokers, and people with complex health conditions in the US showed that an asthma drug, Tezepelumab, led to 70% fewer asthma attacks in people with severe asthma.

They also hear about new hearing technology which can read peoples’ brainwaves to help people to pick out the single voice they want to listen to in a noisy room. Claudia speaks to Nima Mesgarani, Associate Professor at the Zuckerman Institute at Columbia University in New York.

And Claudia and Laura discuss why some cancer patients would fancy a pre-consultation with an AI avatar before a consultation with their real-life doctor?

Presenter: Claudia Hammond Producer: Jonathan Blackwell & Clare Salisbury

Image: A Congolese health worker checks the temperature to screen a traveller at the Grande Barrier border following confirmation of an Ebola outbreak involving the Bundibugyo strain, at the border crossing point between Congo and Rwanda, in Goma, Democratic Republic of Congo May 18, 2026


26min 29sec




FDA approves new Alzheimer’s drug

--:--
--:--